Compare Novartis AG (NVS) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Oklo Inc — how do they compare? Novartis AG trades at $152.4 (market cap $295.37B), while Oklo Inc trades at $47.47 (market cap $8.74B). The key difference: Novartis AG is far larger — about 33.8× Oklo Inc's market cap, and Novartis AG pays a 3.07% dividend while Oklo Inc pays none. Which is the better fit depends on your goals.
| NVS | OKLO | |
|---|---|---|
Market Cap | $295.37B | $8.74B |
Sector | Health | Technology |
52-Week High | $168.62 | $174.14 |
52-Week Low | $119.31 | $36.84 |
Enterprise Value | $336.69B | $6.28B |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
